Tuesday, March 20, 2018
Company News: Page (1) of 1 - 03/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
iSpecimen® Director of Marketing Jeff Goldman to Present Cutting-Edge Biobanking Strategy
Session presented with Science Exchange to feature iSpecimen's approach to solving critical biospecimen procurement challenges
(March 13, 2018)

ZURICH, March 13, 2018 /PRNewswire/ -- iSpecimen Director of Marketing Jeff Goldman and partner Science Exchange will co-present today, March 13, at the ProcureCon Europe Pharma Conference in Switzerland. The presentation will demonstrate how iSpecimen's digital marketplace addresses challenges along the research supply chain, and share industry perspectives on biobanking and procurement.

Since the event's inception in 1999, the annual ProcureCon Pharma Conference has become one of the world's leading international events supporting the procurement field. By showcasing case studies that demonstrate process innovation, new tools, technologies and cutting-edge strategy, its more than 5,000 senior-level executives will be equipped with practical steps on how to better integrate and connect disparate services along the procurement chain.

Goldman's session on the iSpecimen Marketplace will delve into challenges and solutions in biospecimen procurement that are fulfilling the needs of medical researchers who need high-quality samples – including tissue, biofluids and cells – in precision medicine initiatives.

ProcureCon Pharma will take place from March 13-15th in Zurich, Switzerland.

About iSpecimen
Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all. For more information about iSpecimen, please visit www.ispecimen.com.


Cision View original content with multimedia:http://www.prnewswire.com/news-releases/ispecimen-director-of-marketing-jeff-goldman-to-present-cutting-edge-biobanking-strategy-300613348.html

SOURCE iSpecimen

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Science,Science,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • New Alzheimer's Association Report Reveals Sharp Increases in Alzheimer's Prevalence, Deaths and Cost of Care
  • Global Incontinence and Ostomy Care Products Industry
  • Global Anti-Aging Products Industry
  • Brain Ischemia Market 2018 Progress | Size, Potential, Growth and Trend | A Definite Shift towards the Developing World | Forecasts till 2023
  • Refurbished Medical Equipment Market 2018 Global Analysis, Opportunities and Forecast To 2023

  • New Alzheimer's Association Report Reveals Sharp Increases in Alzheimer's Prevalence, Deaths and Cost of Care
  • Global Biopharmaceutical Bioseparation Systems Industry
  • CASI Pharmaceuticals Announces $50 Million Private Placement To Prepare Company For Commercialization In China
  • National Research Council contribution plays key role in newly approved Ebola vaccine
  • Twelve Global Startups Selected To Join New Innovation Platform, Plug and Play Cleveland

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines